Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
2012 · Annals of the Rheumatic Diseases · 158 citations
https://doi.org/10.1136/annrheumdis-2012-202450
E
Ehsanollah Esfandiari
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
916
Citations
10
h-index
11
i10-index
Ehsanollah Esfandiari is an academic researcher from Kyowa Kirin International (United Kingdom). The author has contributed to research in topics: Dermatology and Skin Diseases & Urticaria and Related Conditions & Asthma and respiratory diseases. The author has an h-index of 10, co-authored 29 publications.
Papers by this author
worksInduction of cartilage integration by a chondrocyte/collagen-scaffold implant
2009 · Biomaterials · 93 citations
https://doi.org/10.1016/j.biomaterials.2009.02.052
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
2024 · American Journal of Clinical Dermatology · 64 citations
https://doi.org/10.1007/s40257-023-00838-9
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
2025 · Immunotherapy · 10 citations
https://doi.org/10.1080/1750743x.2025.2464528
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis
2025 · Dermatology and Therapy · 5 citations
https://doi.org/10.1007/s13555-025-01492-1
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
2024 · Advances in Therapy · 3 citations
https://doi.org/10.1007/s12325-023-02755-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat